TD ASSET MANAGEMENT INC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 164 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$753,940
-24.0%
237,836
+19.2%
0.00%0.0%
Q2 2023$991,411
+15.6%
199,479
+14.9%
0.00%0.0%
Q1 2023$857,974
-21.5%
173,6790.0%0.00%0.0%
Q4 2022$1,092,441
-35.7%
173,679
+5.5%
0.00%
-50.0%
Q3 2022$1,699,000
+16.4%
164,679
+28.7%
0.00%0.0%
Q2 2022$1,459,000
+30.9%
127,973
+4.6%
0.00%
+100.0%
Q1 2022$1,115,000
-31.6%
122,373
+12.1%
0.00%0.0%
Q4 2021$1,629,000
-43.1%
109,173
-2.0%
0.00%
-66.7%
Q3 2021$2,862,000
+42.2%
111,365
+21.5%
0.00%
+50.0%
Q2 2021$2,012,000
-30.1%
91,676
+12.5%
0.00%
-33.3%
Q1 2021$2,877,000
+46.3%
81,505
+4.7%
0.00%
+50.0%
Q4 2020$1,966,000
-32.9%
77,873
+0.2%
0.00%
-50.0%
Q3 2020$2,929,000
-17.1%
77,681
-5.8%
0.00%
-20.0%
Q2 2020$3,532,000
+234.8%
82,481
+52.0%
0.01%
+150.0%
Q1 2020$1,055,000
-29.9%
54,275
-6.2%
0.00%0.0%
Q4 2019$1,504,000
-4.6%
57,8750.0%0.00%0.0%
Q3 2019$1,577,000
+1.5%
57,8750.0%0.00%0.0%
Q2 2019$1,554,000
+109.7%
57,875
+125.7%
0.00%
+100.0%
Q1 2019$741,000
+9.9%
25,643
+2.4%
0.00%0.0%
Q4 2018$674,00025,0430.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$16,381,0009.53%
Wildcat Capital Management, LLC 2,128,370$19,389,0004.96%
TPG GP A, LLC 18,716,306$170,506,0002.11%
Pier Capital, LLC 746,669$6,802,0000.87%
Coastal Bridge Advisors, LLC 401,929$3,662,0000.84%
HARBOR CAPITAL ADVISORS, INC. 92,755$845,0000.40%
Lombard Odier Asset Management (Switzerland) SA 501,219$4,566,0000.36%
Navalign, LLC 74,271$623,0000.26%
PDT Partners, LLC 241,592$2,201,0000.19%
GSA CAPITAL PARTNERS LLP 148,804$1,356,0000.18%
View complete list of ALLOGENE THERAPEUTICS INC shareholders